THE major international European rheumatology conference, the European League Against Rheumatism (EULAR), has celebrated 30 years of use of one of its gold standard drugs, methotrexate (MTX), with researchers saying its "potential is far from exhausted".
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jun 18
